The Free Online ADHD Quiz Wants Your Email, Not Just Answers

The object at the center of this story is not obscure. It is six questions long.

The Adult ADHD Self-Report Scale screener, often shortened to ASRS, asks how frequently an adult experiences behaviors associated with attention and executive function. The answer choices run from “never” to “very often.” The screener was developed with support from the World Health Organization and appears in clinical settings, research, downloadable PDFs and, increasingly, commercial telehealth pages.

On a plain sheet, those six questions are a screening tool. Put them behind a search ad, attach an email field, route the result into scheduling software and follow it with treatment promotions, and the same questions become customer acquisition infrastructure.

I followed one version through Cerebral’s public ADHD test pages, stopping before booking care. The journey looked reassuringly clinical: recognizable symptoms, frequency choices, a result framed as a reason to consider professional evaluation. Around that small instrument sat the machinery of an online health business, including account creation, contact capture and prompts toward paid care.

The six questions had not changed. Their job had.

A screener can do two jobs at once

A screening test estimates whether someone may have traits worth evaluating. It is designed to catch possibilities, which means it can produce false positives and cannot establish why a person is struggling. Sleep loss, anxiety, depression, trauma, substance use, medication effects and other conditions can overlap with experiences commonly associated with ADHD.

A diagnosis asks more. A clinician may consider whether symptoms began during childhood, appear in more than one setting, cause meaningful impairment and fit better than competing explanations. The exact evaluation varies, but clicking “often” beside several statements does not perform that work.

Commercial quizzes tend to acknowledge this distinction somewhere. The disclaimer matters. Yet the surrounding design can pull in the other direction, especially when the result arrives with an urgent booking prompt and language that turns uncertainty into a next step the company happens to sell.

This is not necessarily deception. A person who recognizes themselves in a screener may benefit from seeking an evaluation, and telehealth can remove distance, scheduling and stigma barriers. The conflict is more ordinary than a fake-test scandal. The company can offer a legitimate screening instrument while using the moment of recognition to create a sales lead.

That moment is valuable because the user has already supplied the hardest part of the pitch. They have named a problem. They have spent several minutes translating private frustrations into structured answers. By the result screen, the service no longer needs to persuade a generic visitor that ADHD care exists; it needs to convert someone who has just been told their responses may warrant attention.

The email field changes the transaction

A lead is a person whose contact information and behavior suggest they might become a customer. In health care, the term sounds especially cold because the behavior may include symptoms, fears and a late-night attempt to understand why ordinary tasks feel unmanageable.

The funnel usually starts before the first checkbox. A search engine result, social advertisement or publisher page catches a phrase such as “adult ADHD test.” The landing page offers speed and low friction. The visitor completes the screener.

At some point, the service asks for an email address, phone number, account or location, ostensibly to deliver results, check eligibility or find available care.

Once an identifier is attached, the visit can enter a customer relationship management system, software that stores leads and tracks their movement toward a purchase. An email service may send reminders. Scheduling and payment vendors may handle the next steps. Analytics tools record which page or campaign produced the visit.

Advertising technology may help measure whether an ad led to registration, though what those tools receive depends on the site’s configuration and contracts.

This is where the six questions stop being merely six questions. Their commercial meaning comes from linkage. A set of responses without a name may still reveal something sensitive, but an answer set connected to an email address, device identifier, appointment request or advertising profile can become much easier to sort, target and retain.

The score is useful to the visitor. Intent is useful to the seller.

The recipients are not always visible on the page

A person taking a health quiz can reasonably imagine a narrow exchange between themselves and a clinic. Modern websites rarely operate that narrowly.

Data may pass through the company running the quiz, its affiliated clinical practice, cloud hosting providers, form software, analytics services, customer support systems, appointment platforms and payment processors. Some vendors act only under contract. Others may receive limited event data, such as the fact that a page loaded or a registration button was pressed. The distinction matters because “data sharing” can describe very different transfers, from routine hosting to information used for advertising.

Public enforcement shows why the details cannot be waved away. In 2024, the Federal Trade Commission alleged that Cerebral disclosed sensitive consumer information to third-party advertising platforms and failed to honor privacy promises. The FTC’s complaint concerned Cerebral’s broader services and data practices, not a finding that the six-item ADHD screener itself diagnosed users or that every visitor’s answers followed one identical route. Cerebral agreed to an order that included restrictions on using health information for advertising and requirements around deletion and security.

The case matters because Cerebral was a mental health platform, not a quiz site selling novelty personality results. The FTC alleged that tracking tools and marketing systems sat close enough to care-seeking behavior to expose information consumers had reason to treat as private.

HIPAA, the federal health privacy law governing covered health plans, clearinghouses and many providers, does not automatically wrap every wellness page, quiz operator or advertising vendor in the protection people associate with a doctor’s office. Other rules can apply, including the FTC Act, the FTC’s Health Breach Notification Rule and state privacy laws. Coverage depends on who holds the data, why they hold it and how the service is structured.

A privacy policy may name broad categories of recipients while leaving a user to reconstruct the practical route. Reading it also arrives at precisely the wrong moment. The person came to answer six questions, not audit vendor relationships across several linked companies.

Treatment is also the product

Lead generation explains the insistence on contact details. Telehealth businesses spend money to attract prospective patients, and an email address allows repeated attempts to recover that cost through appointment reminders, abandoned-signup messages and promotions for services.

The appointment may lead to an evaluation, therapy, coaching, medication management or a recurring membership, depending on the provider and jurisdiction. Those services are not interchangeable, and a responsible evaluation can conclude that ADHD is not the right explanation. The marketing funnel, however, is built around forward motion. Every extra screen between the quiz and payment creates a place for the visitor to leave.

That incentive shapes the page even without anyone falsifying a result. The strongest conversion path is quick, personalized and emotionally legible. A more clinically honest path is slower. It preserves uncertainty, explains overlapping conditions and makes room for the possibility that the company’s paid offering is not what the visitor needs.

This tension became harder to ignore during the rapid expansion of online mental health care. Public reporting on telehealth prescribing, including scrutiny of Cerebral and Done, has documented how venture-backed growth targets, advertising and controlled-substance treatment collided with clinical obligations. The companies are not identical, and allegations or enforcement involving one service do not establish the practices of another. The common business pressure is still visible: care has to be delivered, but customers also have to be acquired and retained.

A symptom quiz is unusually effective at joining those tasks. It feels like intake before the user has agreed to become a patient.

The useful part can be separated from the funnel

The ASRS screener does not become worthless when a telehealth company publishes it. Nor does completing it commit someone to the service attached to the result. The cleaner alternative already exists: the screener can be read or downloaded without supplying contact information, then discussed with a qualified professional chosen independently of the page that ranked for the search.

That route costs more attention. It may cost time, money and access that a streamlined telehealth service was designed to reduce. Waiting lists are real. Insurance networks can be hostile to anyone who needs executive function to navigate them.

A fast online pathway can be the only pathway a person can realistically use.

The answer is not to shame the person who takes the convenient route. It is to stop treating convenience as proof that the underlying transaction is simple.

Before entering contact information, a visitor can at least see whether results appear without an account, whether marketing consent is optional, how deletion requests work and whether the privacy policy mentions advertising or analytics partners. Those checks do not guarantee control, and this is not medical or legal advice. They reveal whether the page treats a person’s uncertainty as health information, a sales signal or both.

The six questions remain on the screen. What changes is everything attached to the submit button.

Questions people ask

Is an online ADHD screening quiz a diagnosis?

No. A validated screener can indicate that further assessment may be appropriate, but diagnosis requires broader clinical evaluation, including impairment, history and alternative explanations. A commercial result page cannot settle those issues merely by scoring several symptom answers.

Who can receive data from an ADHD quiz?

Depending on the site, recipients may include the quiz operator, an affiliated provider, hosting and form vendors, scheduling systems, analytics companies and advertising platforms. The exact route depends on the page’s code, contracts and privacy policy, which may differ from the protections that apply once someone becomes a patient.

Why does the quiz ask for an email before showing results?

The company may use the address to create an account, deliver the score or connect the visitor with care. It also turns an anonymous visit into a reachable lead that can receive reminders and appointment marketing, making the quiz part of the customer acquisition funnel.

Can a useful screening tool still be marketing?

Yes. The clinical usefulness of the questions and the commercial purpose of the surrounding page can coexist. The relevant issue is whether the service clearly separates screening from diagnosis, limits data collection and lets users see what happens to their information before pushing them toward paid treatment.